Výsledky vyhledávání - "Melika Haghighi"

Akademický článek

Improvement of the inactivated SARS-CoV-2 vaccine potency through formulation in alum/naloxone adjuvant; Robust T cell and anti-RBD IgG responses

Autor: Melika Haghighi, Akbar Khorasani, Pegah Karimi, Mehdi Mahdavi

Publikováno v: Iranian Journal of Basic Medical Sciences, Vol 25, Iss 5, Pp 554-561 (2022)

Objective(s): SARS-CoV-2, emerging as a major threat to public health, has to be controlled through vaccination. Naloxone (NLX), an opioid receptor antagonist, demonstrated its adjuvant activity for microbial vaccines. In this study, inactivated SARS

Externí odkaz: https://doaj.org/article/55b88c3775c24d5eb346d6171073e2cd

Zobrazit plný text záznamu

Different formulations of inactivated SARS-CoV-2 vaccine candidates in human compatible adjuvants: Potency studies in mice showed different platforms of immune responses

Autor: Melika Haghighi, Akbar khorasani, Pegah Karimi, Rouhollah Keshavarz, Mehdi Mahdavi

Several inactivated SARS-CoV-2 vaccines were approved for human use but are not highly potent. Here, different formulations of inactivated SARS-CoV-2 virus in Alum, Montanide 51VG and Montanide ISA720VG adjuvants were developed and then immune respon

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aa13b569d9e6943b066cb4eff242648
https://doi.org/10.21203/rs.3.rs-1067486/v1

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání